Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants.

ABSTRACT:

Importance

There are no data on patient-centered outcomes and health care costs by frailty in patients with atrial fibrillation (AF) taking oral anticoagulants (OACs).

Objective

To compare home time, clinical events, and health care costs associated with OACs by frailty levels in older adults with AF.

Design, setting, and participants

This community-based cohort study assessed Medicare fee-for-service beneficiaries 65 years or older with AF from January 1, 2013, to December 31, 2019. Data analysis was performed from January to December 2022.

Exposures

Apixaban, rivaroxaban, and warfarin use were measured from prescription claims. Frailty was measured using a validated claims-based frailty index.

Main outcomes and measures

Outcome measures were (1) home t

SUBMITTER: Lin KJ 

PROVIDER: S-EPMC10636636 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature